These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21495964)

  • 1. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells.
    Zhao J; Xu Q
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?
    Arias-Carrión O; Yuan TF
    Med Hypotheses; 2009 Nov; 73(5):757-9. PubMed ID: 19467573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell therapy for Parkinson's disease: I. Embryonic and adult donor tissue transplantation].
    Anisimov SV
    Adv Gerontol; 2008; 21(4):575-92. PubMed ID: 19432209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
    Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
    Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell therapy for Parkinson's disease: II. Somatic stem cell-based applications].
    Anisimov SV
    Adv Gerontol; 2009; 22(1):150-66. PubMed ID: 19827685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes.
    Yang H; Hao D; Liu C; Huang D; Chen B; Fan H; Liu C; Zhang L; Zhang Q; An J; Zhao J
    Stem Cell Res Ther; 2019 Jun; 10(1):195. PubMed ID: 31248447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical translation of stem cell transplantation in Parkinson's disease.
    Lindvall O
    J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.
    Zhang L; Yang H
    Mol Biol Rep; 2024 Feb; 51(1):347. PubMed ID: 38400887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
    Kirkeby A; Parmar M; Barker RA
    Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potentials of human embryonic stem cells in Parkinson's disease.
    Newman MB; Bakay RA
    Neurotherapeutics; 2008 Apr; 5(2):237-51. PubMed ID: 18394566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
    Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
    Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular manipulation targeting regulation of dopaminergic differentiation and proliferation of neural stem cells or pluripotent stem cells.
    Ding YX; Wei LC; Wang YZ; Cao R; Wang X; Chen LW
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):517-28. PubMed ID: 21495963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell therapy for Parkinson's disease: III. Neonatal, fetal and embryonic stem cell-based applications].
    Anisimov SV
    Adv Gerontol; 2009; 22(2):296-315. PubMed ID: 19947394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.